Pheochromocytoma
Open Access
- 1 July 2019
- journal article
- review article
- Published by Walter de Gruyter GmbH in Endocrine Regulations
- Vol. 53 (3), 191-212
- https://doi.org/10.2478/enr-2019-0020
Abstract
Pheochromocytomas are rare tumors originating in the adrenal medulla. They may be sporadic or in the context of a hereditary syndrome. A considerable number of pheochromocytomas carry germline or somatic gene mutations, which are inherited in the autosomal dominant way. All patients should undergo genetic testing. Symptoms are due to catecholamines over production or to a mass effect. Diagnosis is confirmed by raised plasma or urine metanephrines or normetanephrines. Radiology assists in the tumor location and any local invasion or metastasis. All the patients should have preoperative preparation with α-blockers and/or other medications to control hypertension, arrhythmia, and volume expansion. Surgery is the definitive treatment. Follow up should be life-long.Keywords
This publication has 146 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Hypoxia-Inducible Factors in Physiology and MedicineCell, 2012
- HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionNature Reviews Cancer, 2011
- Revisiting the TCA cycle: signaling to tumor formationTrends in Molecular Medicine, 2011
- Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1Cell, 2011
- Targeting HIF1α Eliminates Cancer Stem Cells in Hematological MalignanciesCell Stem Cell, 2011
- Hypoxia-Inducible Factors and the Response to Hypoxic StressMolecular Cell, 2010
- ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason GradingCancer Cell, 2010
- New imaging approaches to phaeochromocytomas and paragangliomasClinical Endocrinology, 2010
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeuticsOncogene, 2009